Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ZYNLONTA | loncastuximab tesirine | injection, powder, lyophilized, for solution, intravenous | 79952-110BLA |
Enquiry
Common questions
- Is ADC Therapeutics America, Inc. FDA approved?
- ADC Therapeutics America, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does ADC Therapeutics America, Inc. make?
- 1 product is listed under ADC Therapeutics America, Inc. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.